# Trial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain Metastases

> **NCT02132598** · PHASE2 · TERMINATED · sponsor: **Liza Villaruz, MD** · enrollment: 5 (actual)

## Conditions studied

- Non Small Cell Lung Cancer (NSCLC)
- Metastases to the Brain

## Interventions

- **DRUG:** cabozantinib

## Key facts

- **NCT ID:** NCT02132598
- **Lead sponsor:** Liza Villaruz, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-12
- **Primary completion:** 2019-08-09
- **Final completion:** 2019-08-09
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Trial stopped due to slow patient accrual.
- **Last updated:** 2021-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02132598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02132598, "Trial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain Metastases". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02132598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*